Thermo Fisher Scientific Inc (TMO)
550.78
-7.39
(-1.32%)
USD |
NYSE |
Jun 27, 16:00
550.78
0.00 (0.00%)
Pre-Market: 06:25
Thermo Fisher Scientific Accounts Receivable (Quarterly): 7.931B for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 7.931B |
December 31, 2023 | 8.221B |
September 30, 2023 | 8.37B |
June 30, 2023 | 8.019B |
March 31, 2023 | 7.922B |
December 31, 2022 | 8.115B |
September 30, 2022 | 7.671B |
June 30, 2022 | 7.745B |
March 31, 2022 | 7.889B |
December 31, 2021 | 7.977B |
September 30, 2021 | 5.557B |
June 30, 2021 | 5.476B |
March 31, 2021 | 5.554B |
December 31, 2020 | 5.741B |
September 30, 2020 | 5.186B |
June 30, 2020 | 4.478B |
March 31, 2020 | 4.508B |
December 31, 2019 | 4.349B |
September 30, 2019 | 4.384B |
June 30, 2019 | 4.129B |
March 31, 2019 | 4.155B |
December 31, 2018 | 4.136B |
September 30, 2018 | 3.852B |
June 30, 2018 | 3.911B |
March 31, 2018 | 3.99B |
Date | Value |
---|---|
December 31, 2017 | 3.879B |
September 30, 2017 | 3.657B |
June 30, 2017 | 3.258B |
March 31, 2017 | 3.096B |
December 31, 2016 | 3.049B |
September 30, 2016 | 2.895B |
June 30, 2016 | 2.709B |
March 31, 2016 | 2.668B |
December 31, 2015 | 2.545B |
September 30, 2015 | 2.544B |
June 30, 2015 | 2.631B |
March 31, 2015 | 2.538B |
December 31, 2014 | 2.474B |
September 30, 2014 | 2.507B |
June 30, 2014 | 2.660B |
March 31, 2014 | 2.696B |
December 31, 2013 | 1.942B |
September 30, 2013 | 1.945B |
June 30, 2013 | 1.902B |
March 31, 2013 | 1.904B |
December 31, 2012 | 1.805B |
September 30, 2012 | 1.829B |
June 30, 2012 | 1.804B |
March 31, 2012 | 1.895B |
December 31, 2011 | 1.764B |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
4.129B
Minimum
Jun 2019
8.37B
Maximum
Sep 2023
6.461B
Average
6.706B
Median
Accounts Receivable (Quarterly) Benchmarks
Fonar Corp | 26.92M |
XWELL Inc | 2.90M |
ProPhase Labs Inc | 35.12M |
Applied DNA Sciences Inc | 0.4089M |
Veracyte Inc | 46.66M |